Torsemide Tablet
Product Images NDC 0615-8521

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Torsemide (NDC 0615-8521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Torsemide 8521 1)

Structural Formula (Torsemide 8521 1)
Chemical structure of Torsemide, depicting its molecular components including pyridine rings, sulfonamide group, and other functional groups characteristic of the active ingredient Torsemide.*
FDA Label Image

Principal Display Panel (Torsemide 8521 2)

Principal Display Panel (Torsemide 8521 2)
Torsemide Tablets 10 mg bottle label for oral use by NCS HealthCare of KY, LLC dba Vangard Labs. The label indicates a quantity of 30 tablets, manufactured by Pliva Hrvatska for Teva. Includes multiple barcode strips with lot number 8521-, storage instructions, and a section marked FOR INSTITUTIONAL USE ONLY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.